TYRA

TYRA

USD

Tyra Biosciences Inc. Common Stock

$15.000-0.210 (-1.381%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$15.210

High

$15.720

Low

$14.540

Volume

0.09M

Company Fundamentals

Market Cap

799.5M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.22M

Exchange

NMS

Currency

USD

52-Week Range

Low $6.42Current $15.000High $17.78

Related News

Analyst Upgrades

Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35

Raymond James analyst Chris Raymond initiates coverage on Tyra Biosciences with a Strong Buy rating and announces Price Target of $35.

View more
Raymond James Initiates Coverage On Tyra Biosciences with Strong Buy Rating, Announces Price Target of $35
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Tyra Biosciences with a Buy and maintains $30 price target.

View more
HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $30 Price Target
PR Newswire

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

View more
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
PR Newswire

Tyra Biosciences Announces Participation at Upcoming Investor Events

Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target...

View more
Tyra Biosciences Announces Participation at Upcoming Investor Events